Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry

Chemical Research in Toxicology

Volumn 25, Issue 5, 2012, Pages 1119-1131

  Yun, Byeong Hwa ^a   Rosenquist, Thomas A ^b   Sidorenko, Viktoriya ^b   Iden, Charles R ^b   Chen, Chung Hsin ^c   Pu, Yeong Shiau ^c   Bonala, Radha ^b   Johnson, Francis ^b   Dickman, Kathleen G ^b   Grollman, Arthur P ^b   Turesky, Robert J ^a  

^a WADSWORTH CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

7(DEOXYADENOSIN YL) 8 METHOXY 6 NITROPHENANTHRO [3,4 D] 1,3 DIOXOLO 5 CARBOXYLIC ACID; ARISTOLOLACTAM; DNA BASE; PHOSPHORUS 32; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CANCER PATIENT; CARCINOGEN DNA INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; ION TRAP MASS SPECTROMETRY; ISOTOPE LABELING; KIDNEY CORTEX; KIDNEY DISEASE; LIMIT OF QUANTITATION; MALE; MASS SPECTROMETER; MOUSE; NONHUMAN; SENSITIVITY AND SPECIFICITY; TAIWAN; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY TRACT CARCINOMA;

ADULT; AGED; ANIMALS; ARISTOLOCHIA; ARISTOLOCHIC ACIDS; BALKAN NEPHROPATHY; CHROMATOGRAPHY, LIQUID; DNA ADDUCTS; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; LIMIT OF DETECTION; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ARISTOLOCHIA; RODENTIA;

EID: 84861325737     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx3000889     Document Type: Article

References (51)

1. Dawson, D. R. (1927) Birthwort: a study of the progress of medical botany through twenty-two centuries Pharm. J. Pharm. 396-397, 427-430
2. Grollman, A. P. and Scarborough, J., and Jelaković, B. (2009) Aristolochic Acid Nephropathy: An Environmental and Iatrogenic Disease, in Advances in Molecular Toxicology (Fishbein, J., Ed.) Vol. 3, pp 211-222, Elsevier, Amsterdam.
3. Vanherweghem, J. L., Debelle, F. D., Muniz Martinez, M. C., and Nortier, J. L. (2003) Aristolochic Acid Nephropathy after Chinese Herb Remedies, in Clinical Nephrotoxins (De Broe, M. E., Porter, G. A., Bennett, W. M., and Verpooten, G. A., Eds.) 2 nd ed., pp 579-603, Kluwer, Dordrecht, The Netherlands.
4. Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., Jakovina, K., Brdar, B., Slade, N., Turesky, R. J., Goodenough, A. K., Rieger, R., Vukelic, M., and Jelakovic, B. (2007) Aristolochic acid and the etiology of endemic (Balkan) nephropathy Proc. Natl. Acad. Sci. U.S.A. 104, 12129-12134
5. Jelaković, B., Karanović, S., Vuković-Lela, I., Miller, F., Edwards, K. L., Nikolić, J., Tomić, K., Slade, N., Brdar, B., Turesky, R. J., Stipancić, Z., Dittrich, D., Grollman, A. P., and Dickman, K. G. (2011) Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid Kidney Int. 81, 559-567
6. Nortier, J. L., Martinez, M. C., Schmeiser, H. H., Arlt, V. M., Bieler, C. A., Petein, M., Depierreux, M. F., De, P. L., Abramowicz, D., Vereerstraeten, P., and Vanherweghem, J. L. (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) N. Engl. J. Med. 342, 1686-1692
7. Petronić, V. (2000) Tumors of the upper urothelium and endemic nephropathy, in Endemic Nephropathy. Institute for Textbook Publishing, (Radovanović, Z., Sindić, M., Polenaković, M., Djukanović, L., and Petronić, V., and Petronić, V., Eds.) pp 350-439, Institute for Text Book Publishing, Belgrade, Serbia.
8. Debelle, F. D., Vanherweghem, J. L., and Nortier, J. L. (2008) Aristolochic acid nephropathy: a worldwide problem Kidney Int. 74, 158-169
9. Lai, M. N., Wang, S. M., Chen, P. C., Chen, Y. Y., and Wang, J. D. (2010) Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk J. Natl. Cancer Inst. 102, 179-186
10. Chen, C.-H., Dickman, K. G., Moriya, M., Zavadil, J., Sidorenko, V., Edwards, K. G., Gnatenko, D., Wu, L., Turesky, R. J., Pu, Y.-S., and Grollman, A. P. Aristolochic acid-associated urothelial carcinoma in Taiwan is a harbinger of a global disease. Proc. Natl. Acad. Sci. U.S.A. 2012, in press.
11. Moriya, M., Slade, N., Brdar, B., Medverec, Z., Tomic, K., Jelakovic, B., Wu, L., Truong, S., Fernandes, A., and Grollman, A. P. (2011) TP53 Mutational signature for aristolochic acid: an environmental carcinogen Int. J. Cancer 129, 1532-1536
12. Pfau, W., Schmeiser, H. H., and Wiessler, M. (1990) Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA Carcinogenesis 11, 313-319
13. Arlt, V. M., Stiborova, M., and Schmeiser, H. H. (2002) Aristolochic acid as a probable human cancer hazard in herbal remedies: a review Mutagenesis 17, 265-277
14. 32P-postlabeling/ polyacrylamide gel electrophoresis analysis Drug Metab. Dispos. 34, 1122-1127
15. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy Carcinogenesis 18, 1063-1067
16. Schmeiser, H. H., Bieler, C. A., Wiessler, M., van Ypersele De, S. C., and Cosyns, J. P. (1996) Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy Cancer Res. 56, 2025-2028
17. Nedelko, T., Arlt, V. M., Phillips, D. H., and Hollstein, M. (2009) TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours Int. J. Cancer 124, 987-990
18. Attaluri, S., Bonala, R. R., Yang, I. Y., Lukin, M. A., Wen, Y., Grollman, A. P., Moriya, M., Iden, C. R., and Johnson, F. (2010) DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells Nucleic Acids Res. 38, 339-352
19. 32P-postlabelling analysis of bulky aromatic adducts IARC Sci. Publ. 124, 11-23
20. 32P- Postlabeling DNA Damage Assay: PAGE, TLC and HPLC, in DNA Repair Protocols: Eukaryotic Systems (Henderson, D. S., Ed.) 2 nd ed., pp 307-321, Humana Press Inc., Totawa, NJ.
21. Phillips, D. H. (2002) Smoking-related DNA and protein adducts in human tissues Carcinogenesis 23, 1979-2004
22. Gu, D., Turesky, R. J., Tao, Y., Langouet, S. A., Nauwelaers, G. C., Yuan, J. M., Yee, D., and Yu, M. C. (2012) DNA adducts of 2-amino-1-methyl-6- phenylimidazo[4,5- b ]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry Carcinogenesis 33, 124-130
23. Koc, H. and Swenberg, J. A. (2002) Applications of mass spectrometry for quantitation of DNA adducts J. Chromatogr., B 778, 323-343
24. Singh, R. and Farmer, P. B. (2006) Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection Carcinogenesis 27, 178-196
25. Bessette, E. E., Spivack, S. D., Goodenough, A. K., Wang, T., Pinto, S., Kadlubar, F. F., and Turesky, R. J. (2010) Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry Chem. Res. Toxicol. 23, 1234-1244
26. n method for the characterization and quantification of 2′-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry Chem. Res. Toxicol. 20, 263-276
27. Chan, W., Yue, H., Poon, W. T., Chan, Y. W., Schmitz, O. J., Kwong, D. W., Wong, R. N., and Cai, Z. (2008) Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry Mutat. Res. 646, 17-24
28. Chan, W., Zheng, Y., and Cai, Z. (2007) Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids J. Am. Soc. Mass Spectrom. 18, 642-650
29. Schmeiser, H. H., Frei, E., Wiessler, M., and Stiborova, M. (1997) Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases Carcinogenesis 18, 1055-1062
30. MacDougall, D., Amore, F. J., Cox, G. V., Crosby, D. G., Estes, F. L., Freeman, D. H., Gibbs, W. E., Gordon, G. E., Keith, L. H., Lal, J., Langner, R. R., McClelland, N. I., Phillips, W. F., Pojasek, R. B., and Sievers, R. E. (1980) Guidelines for data acquistion and data quality evaluation in environmental chemistry Anal. Chem. 52, 2242-2249
31. Harris, C. C., Weston, A., Willey, J. C., Trivers, G. E., and Mann, D. L. (1987) Biochemical and molecular epidemiology of human cancer: indicators of carcinogen exposure, DNA damage, and genetic predisposition Environ. Health Perspect. 75, 109-119
32. Jarabek, A. M., Pottenger, L. H., Andrews, L. S., Casciano, D., Embry, M. R., Kim, J. H., Preston, R. J., Reddy, M. V., Schoeny, R., Shuker, D., Skare, J., Swenberg, J., Williams, G. M., and Zeiger, E. (2009) Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization Crit. Rev. Toxicol. 39, 659-678
33. Phillips, D. H. (2005) DNA adducts as markers of exposure and risk Mutat. Res. 577, 284-292
34. 32P- postlabelling analysis of the DNA adducts formed by aristolochic acid I and II Carcinogenesis 11, 1627-1633
35. Randerath, K., Randerath, E., Agrawal, H. P., Gupta, R. C., Schurda, M. E., and Reddy, M. V. (1985) Postlabeling methods for carcinogen-DNA adduct analysis Environ. Health Perspect. 62, 57-65
36. Phillips, D. H., Farmer, P. B., Beland, F. A., Nath, R. G., Poirier, M. C., Reddy, M. V., and Turteltaub, K. W. (2000) Methods of DNA adduct determination and their application to testing compounds for genotoxicity Environ. Mol. Mutagen. 35, 222-233
37. Soglia, J. R., Turesky, R. J., Paehler, A., and Vouros, P. (2001) Quantification of the heterocyclic aromatic amine DNA adduct N-(deoxyguanosin-8-yl)-2-amino-3-methylimidazo[4,5-f]quinoline in livers of rats using capillary liquid chromatography/microelectrospray mass spectrometry: a dose-response study Anal. Chem. 73, 2819-2827
38. Beland, F. A., Doerge, D. R., Churchwell, M. I., Poirier, M. C., Schoket, B., and Marques, M. M. (1999) Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard Chem. Res. Toxicol. 12, 68-77
39. Beland, F. A., Churchwell, M. I., Von Tungeln, L. S., Chen, S., Fu, P. P., Culp, S. J., Schoket, B., Gyorffy, E., Minarovits, J., Poirier, M. C., Bowman, E. D., Weston, A., and Doerge, D. R. (2005) High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts Chem. Res. Toxicol. 18, 1306-1315
40. Turesky, R. J. and Vouros, P. (2004) Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo J. Chromatogr., B 802, 155-166
41. Bessette, E. E., Goodenough, A. K., Langouet, S., Yasa, I., Kozekov, I. D., Spivack, S. D., and Turesky, R. J. (2009) Screening for DNA adducts by data-dependent constant neutral loss-triple stage mass spectrometry with a linear quadrupole ion trap mass spectrometer Anal. Chem. 81, 809-819
42. Turesky, R. J., Bendaly, J., Yasa, I., Doll, M. A., and Hein, D. W. (2009) The impact of NAT2 acetylator genotype on mutagenesis and DNA adducts from 2-amino-9H-pyrido[2,3-b]indole Chem. Res. Toxicol. 22, 726-733
43. Zhang, S., Villalta, P. W., Wang, M., and Hecht, S. S. (2006) Analysis of crotonaldehyde- and acetaldehyde-derived 1,n(2)-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry Chem. Res. Toxicol. 19, 1386-1392
44. Wang, M., Yu, N., Chen, L., Villalta, P. W., Hochalter, J. B., and Hecht, S. S. (2006) Identification of an acetaldehyde adduct in human liver DNA and quantitation as N2-ethyldeoxyguanosine Chem. Res. Toxicol. 19, 319-324
45. Zhang, S., Villalta, P. W., Wang, M., and Hecht, S. S. (2007) Detection and quantitation of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry Chem. Res. Toxicol. 20, 565-571
46. Medeiros, M. H. (2009) Exocyclic DNA adducts as biomarkers of lipid oxidation and predictors of disease. Challenges in developing sensitive and specific methods for clinical studies Chem. Res. Toxicol. 22, 419-425
47. Ricicki, E. M., Soglia, J. R., Teitel, C., Kane, R., Kadlubar, F., and Vouros, P. (2005) Detection and quantification of N-(deoxyguanosin-8-yl)-4- aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry Chem. Res. Toxicol. 18, 692-699
48. Zayas, B., Stillwell, S. W., Wishnok, J. S., Trudel, L. J., Skipper, P., Yu, M. C., Tannenbaum, S. R., and Wogan, G. N. (2007) Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients Carcinogenesis 28, 342-349
49. Chan, W., Hui, K. M., Poon, W. T., Lee, K. C., and Cai, Z. (2006) Differentiation of herbs linked to "Chinese herb nephropathy" from the liquid chromatographic determination of aristolochic acids Anal. Chim. Acta 576, 112-116
50. (2008) Aristolochic Acids, in National Toxicology Program Report on Carcinogens, 12 th ed., US Department of Health and Human Services, Public Health Service, Research Triangle Park, NC.
51. Sidorenko, V. S., Yeo, J. E., Bonala, R. R., Johnson, F., Scharer, O. D., and Grollman, A. P. (2012) Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts Nucleic Acids Res. 40, 2494-2505